Show
Sort by
-
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
-
Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)
-
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial
-
- Journal Article
- A1
- open access
Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
-
Epigenetic sampling effects : nephrectomy modifies the clear cell renal cell cancer methylome
-
- Journal Article
- A1
- open access
Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
-
Effect of sunitinib treatment on mutations and methylation in metastatic renal cancer